A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer

A Sequential Method of Epidermal Growth Factor Receptor Mutation Detection Reduces False Negatives: A New Case With Doublet Mutations of L833V and H835L in China

(2013) Yuan Zhuang et al.   Clinical Lung Cancer

Comparison of molecular testing methods for the detection ofEGFRmutations in formalin-fixed paraffin-embedded tissue specimens of non-small cell lung cancer

(2013) Fernando Lopez-Rios et al.   JOURNAL OF CLINICAL PATHOLOGY

An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting

(2012) K. Goto et al.   ANNALS OF ONCOLOGY

Direct Comparison of 3 PCR Methods in Detecting EGFR Mutations in Patients with Advanced Non–Small-Cell Lung Cancer

(2012) Takaya Ikeda et al.   Clinical Lung Cancer

EGFRmutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples

(2012) Gillian Ellison et al.   JOURNAL OF CLINICAL PATHOLOGY

A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry

(2012) Bárbara Angulo et al.   PLoS One

EGFR Exon 19 Insertions: A New Family of Sensitizing EGFR Mutations in Lung Adenocarcinoma

(2011) M. He et al.   CLINICAL CANCER RESEARCH

EGFR mutations in non-small-cell lung cancer among smokers and non-smokers: A meta-analysis

(2011) Jing-Hua Ren et al.   ENVIRONMENTAL AND MOLECULAR MUTAGENESIS

Establishing an EGFR mutation screening service for non-small cell lung cancer – Sample quality criteria and candidate histological predictors

(2011) Alexandra F. Leary et al.   EUROPEAN JOURNAL OF CANCER

Good Response to Gefitinib in a Lung Adenocarcinoma Harboring a Heterozygous Complex Mutation of L833V and H835L in Epidermal Growth Factor Receptor Gene

(2011) Tsung-Ying Yang et al.   JOURNAL OF CLINICAL ONCOLOGY

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

(2011) Masahiro Fukuoka et al.   JOURNAL OF CLINICAL ONCOLOGY

Relative Abundance of EGFR Mutations Predicts Benefit From Gefitinib Treatment for Advanced Non–Small-Cell Lung Cancer

(2011) Qing Zhou et al.   JOURNAL OF CLINICAL ONCOLOGY

American Society of Clinical Oncology Provisional Clinical Opinion: Epidermal Growth Factor Receptor (EGFR) Mutation Testing for Patients With Advanced Non–Small-Cell Lung Cancer Considering First-Line EGFR Tyrosine Kinase Inhibitor Therapy

(2011) Vicki Leigh Keedy et al.   JOURNAL OF CLINICAL ONCOLOGY

A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patients

(2011) Yi Liu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Tyrosine Kinase Inhibitors and Epidermal Growth Factor Receptor (EGFR) Mutations in Non-Small Cell Lung Cancer

(2011) Adi F. Gazdar   MEDICINE

Detection of Somatic Mutations by High-Resolution DNA Melting (HRM) Analysis in Multiple Cancers

(2011) Jesus Gonzalez-Bosquet et al.   PLoS One

ASCO Provisional Clinical Opinion: Epidermal Growth Factor Receptor Mutation Testing in Practice

(2011) Mary Beth Beasley et al.   Journal of Oncology Practice

Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas

(2010) Zhiyong Liang et al.   BMC CANCER

A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples

(2010) Gillian Ellison et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Consensus for EGFR Mutation Testing in Non-small Cell Lung Cancer: Results from a European Workshop

(2010) Robert Pirker et al.   Journal of Thoracic Oncology

EGFR mutation detection in NSCLC—assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC

(2010) Roland Penzel et al.   VIRCHOWS ARCHIV

Molecular Predictors of Outcome With Gefitinib and Docetaxel in Previously Treated Non–Small-Cell Lung Cancer: Data From the Randomized Phase III INTEREST Trial

(2009) Jean-Yves Douillard et al.   JOURNAL OF CLINICAL ONCOLOGY

Detection of EGFR and KRAS mutations on trans-thoracic needle aspiration of lung nodules by high resolution melting analysis

(2009) A Fassina et al.   JOURNAL OF CLINICAL PATHOLOGY

KRAS Mutation

(2009) Wilbur A. Franklin et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

(2009) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE

High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies

(2008) Hongdo Do et al.   BMC CANCER

High-resolution DNA melting analysis: advancements and limitations

(2008) Carl T. Wittwer   HUMAN MUTATION